These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 23801557)

  • 1. Emerging antiviral strategies to interfere with influenza virus entry.
    Vanderlinden E; Naesens L
    Med Res Rev; 2014 Mar; 34(2):301-39. PubMed ID: 23801557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses.
    Chen HW; Cheng JX; Liu MT; King K; Peng JY; Zhang XQ; Wang CH; Shresta S; Schooley RT; Liu YT
    Antiviral Res; 2013 Sep; 99(3):371-82. PubMed ID: 23820269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pyrrolo[3,2-c]pyridin-4-amine compounds as a new class of entry inhibitors against influenza viruses in vitro.
    Chang SY; Cruz DJ; Ko Y; Min JY
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1594-601. PubMed ID: 27586275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective of Use of Antiviral Peptides against Influenza Virus.
    Skalickova S; Heger Z; Krejcova L; Pekarik V; Bastl K; Janda J; Kostolansky F; Vareckova E; Zitka O; Adam V; Kizek R
    Viruses; 2015 Oct; 7(10):5428-42. PubMed ID: 26492266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Influenza Virus Entry Inhibitor Targets Class II PI3 Kinase and Synergizes with Oseltamivir.
    O'Hanlon R; Leyva-Grado VH; Sourisseau M; Evans MJ; Shaw ML
    ACS Infect Dis; 2019 Oct; 5(10):1779-1793. PubMed ID: 31448902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors targeting the influenza virus hemagglutinin.
    Li F; Ma C; Wang J
    Curr Med Chem; 2015; 22(11):1361-82. PubMed ID: 25723505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies of development of antiviral agents directed against influenza virus replication.
    Hsieh HP; Hsu JT
    Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.
    Kim M; Kim SY; Lee HW; Shin JS; Kim P; Jung YS; Jeong HS; Hyun JK; Lee CK
    Antiviral Res; 2013 Nov; 100(2):460-72. PubMed ID: 23954192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus entry.
    Luo M
    Adv Exp Med Biol; 2012; 726():201-21. PubMed ID: 22297515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.
    Jang Y; Shin JS; Yoon YS; Go YY; Lee HW; Kwon OS; Park S; Park MS; Kim M
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral strategies against influenza virus: towards new therapeutic approaches.
    Loregian A; Mercorelli B; Nannetti G; Compagnin C; Palù G
    Cell Mol Life Sci; 2014 Oct; 71(19):3659-83. PubMed ID: 24699705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ching-fang-pai-tu-san inhibits the release of influenza virus.
    Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
    J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.
    Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R
    J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus.
    Jang Y; Shin JS; Lee JY; Shin H; Kim SJ; Kim M
    Viruses; 2020 May; 12(5):. PubMed ID: 32466302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza viruses: basic biology and potential drug targets.
    Basler CF
    Infect Disord Drug Targets; 2007 Dec; 7(4):282-93. PubMed ID: 18220960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense.
    Tran TT; Kim M; Jang Y; Lee HW; Nguyen HT; Nguyen TN; Park HW; Le Dang Q; Kim JC
    BMC Complement Altern Med; 2017 Mar; 17(1):162. PubMed ID: 28327126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.